B

Binex Co Ltd
KOSDAQ:053030

Watchlist Manager
Binex Co Ltd
KOSDAQ:053030
Watchlist
Price: 16 260 KRW -3.5% Market Closed
Market Cap: 517.8B KRW
Have any thoughts about
Binex Co Ltd?
Write Note

Binex Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Binex Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
B
Binex Co Ltd
KOSDAQ:053030
Interest Income Expense
-â‚©2.5B
CAGR 3-Years
-98%
CAGR 5-Years
-16%
CAGR 10-Years
-21%
Yuhan Corp
KRX:000100
Interest Income Expense
â‚©51.5B
CAGR 3-Years
-14%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
SK Biopharmaceuticals Co Ltd
KRX:326030
Interest Income Expense
-â‚©11.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Interest Income Expense
-â‚©15.4B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Interest Income Expense
â‚©7.8B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
19%
C
Celltrion Pharm Inc
KOSDAQ:068760
Interest Income Expense
-â‚©6.7B
CAGR 3-Years
-15%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
No Stocks Found

Binex Co Ltd
Glance View

Market Cap
502.8B KRW
Industry
Pharmaceuticals

BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Busan, Busan. The company went IPO on 2001-08-07. The Company’s products include digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as ointment, creams and others. The company also manufactures bio medicines and raw materials. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
10 997.49 KRW
Overvaluation 32%
Intrinsic Value
Price
B

See Also

What is Binex Co Ltd's Interest Income Expense?
Interest Income Expense
-2.5B KRW

Based on the financial report for Jun 30, 2024, Binex Co Ltd's Interest Income Expense amounts to -2.5B KRW.

What is Binex Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-21%

Over the last year, the Interest Income Expense growth was -74%. The average annual Interest Income Expense growth rates for Binex Co Ltd have been -98% over the past three years , -16% over the past five years , and -21% over the past ten years .

Back to Top